Ignite Creation Date:
2024-05-06 @ 10:33 AM
Last Modification Date:
2024-10-26 @ 12:31 PM
Study NCT ID:
NCT03280030
Status:
COMPLETED
Last Update Posted:
2023-04-19
First Post:
2017-09-08
Brief Title:
A Study of Midostaurin Efficacy and Safety in Newly Diagnosed Patients With FLT3-mutated AML
Sponsor:
Novartis Pharmaceuticals
Organization:
Novartis